High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma

Abstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular...

Full description

Bibliographic Details
Main Authors: Wei Mu, Yaoli Xie, Jinhu Li, Runzhi Yan, Jingxian Zhang, Yu’e Liu, Yimin Fan
Format: Article
Language:English
Published: BMC 2022-01-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-021-02479-w
_version_ 1818954037257568256
author Wei Mu
Yaoli Xie
Jinhu Li
Runzhi Yan
Jingxian Zhang
Yu’e Liu
Yimin Fan
author_facet Wei Mu
Yaoli Xie
Jinhu Li
Runzhi Yan
Jingxian Zhang
Yu’e Liu
Yimin Fan
author_sort Wei Mu
collection DOAJ
description Abstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular carcinoma (HCC) remains unclear. Therefore, we evaluated the prognostic role of PBK and its correlation with immune infiltrates in hepatocellular carcinoma. Methods The expression of PBK in pan-cancers was studied by Onconmine and TIMER. The expression of PBK in HCC patients and its relationship with clinicopathological characteristics were analyzed using The Gene Expression Profiling Interactive Analysis (GEPIA), The human protein atlas database (HPA), The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases. Receiver operating characteristic (ROC) curve was used to determine the diagnostic value of PBK in HCC patients. The relationship between PBK and prognosis of HCC was performed by GEPIA and Kaplan Meier plotter web tool. The correlations between the clinical characteristics and overall survival were analyzed by Univariate Cox regression and Multivariate Cox hazards regression to identify possible prognostic factors for HCC patients. LinkedOmics was applied to investigate co-expression associated with PBK and to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The network map of PBK and related genes is constructed by GeneMANIA. Finally, TIMER and TISIDB were used to analyze the correlations between PBK and tumor-infiltrating immune cells. Results Multiple database analysis shows that PBK was highly expressed in many types of tumors, including hepatocellular carcinoma, and was significantly related to tumor stage (P=0.0089), age (P=0.0131), and race (P=0.0024) of HCC patients. The receiver operating characteristic (ROC) curve analysis showed that PBK had high diagnostic potential to HCC in GSE76427 (AUC=0.8799), GSE121248 (AUC=0.9224), GSE62232 (AUC=0.9975), and GSE84402 (AUC=0.9541). Multivariate Cox hazards regression showed that high expression of PBK may be an independent risk factor for overall survival in HCC patients (HR = 1.566, 95% CI=1.062–2.311, P= 0.024). The Protein–protein interaction network showed that PBK significantly interacted with LRRC47, ARAF, LGALS9B, TTK, DLG1, and other essential genes. Furthermore, enrichment analysis showed that PBK and co-expressed genes participated in many biological processes, cell composition, molecular functions, and pathways in HCC. Finally, the immune infiltration analysis by TIMER and TISIDB indicated that a significant tightly correlation between PBK and macrophages, neutrophils, as well as chemokines and receptors. Conclusions High expression of PBK is significantly correlated with poor survival and immune infiltrates in hepatocellular carcinoma. Our study suggests that PBK can be used as a biomarker of poor prognosis and potential immune therapy target in hepatocellular carcinoma.
first_indexed 2024-12-20T10:15:48Z
format Article
id doaj.art-3ca73d3117094855bb63d6fdda512d40
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-20T10:15:48Z
publishDate 2022-01-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-3ca73d3117094855bb63d6fdda512d402022-12-21T19:44:04ZengBMCWorld Journal of Surgical Oncology1477-78192022-01-0120111310.1186/s12957-021-02479-wHigh expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinomaWei Mu0Yaoli Xie1Jinhu Li2Runzhi Yan3Jingxian Zhang4Yu’e Liu5Yimin Fan6Department of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Physiology, Shanxi Medical UniversityDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Interventional Radiology, Shanxi Provincial People’s HospitalDepartment of Interventional Radiology, Shanxi Provincial People’s HospitalDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityAbstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular carcinoma (HCC) remains unclear. Therefore, we evaluated the prognostic role of PBK and its correlation with immune infiltrates in hepatocellular carcinoma. Methods The expression of PBK in pan-cancers was studied by Onconmine and TIMER. The expression of PBK in HCC patients and its relationship with clinicopathological characteristics were analyzed using The Gene Expression Profiling Interactive Analysis (GEPIA), The human protein atlas database (HPA), The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases. Receiver operating characteristic (ROC) curve was used to determine the diagnostic value of PBK in HCC patients. The relationship between PBK and prognosis of HCC was performed by GEPIA and Kaplan Meier plotter web tool. The correlations between the clinical characteristics and overall survival were analyzed by Univariate Cox regression and Multivariate Cox hazards regression to identify possible prognostic factors for HCC patients. LinkedOmics was applied to investigate co-expression associated with PBK and to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The network map of PBK and related genes is constructed by GeneMANIA. Finally, TIMER and TISIDB were used to analyze the correlations between PBK and tumor-infiltrating immune cells. Results Multiple database analysis shows that PBK was highly expressed in many types of tumors, including hepatocellular carcinoma, and was significantly related to tumor stage (P=0.0089), age (P=0.0131), and race (P=0.0024) of HCC patients. The receiver operating characteristic (ROC) curve analysis showed that PBK had high diagnostic potential to HCC in GSE76427 (AUC=0.8799), GSE121248 (AUC=0.9224), GSE62232 (AUC=0.9975), and GSE84402 (AUC=0.9541). Multivariate Cox hazards regression showed that high expression of PBK may be an independent risk factor for overall survival in HCC patients (HR = 1.566, 95% CI=1.062–2.311, P= 0.024). The Protein–protein interaction network showed that PBK significantly interacted with LRRC47, ARAF, LGALS9B, TTK, DLG1, and other essential genes. Furthermore, enrichment analysis showed that PBK and co-expressed genes participated in many biological processes, cell composition, molecular functions, and pathways in HCC. Finally, the immune infiltration analysis by TIMER and TISIDB indicated that a significant tightly correlation between PBK and macrophages, neutrophils, as well as chemokines and receptors. Conclusions High expression of PBK is significantly correlated with poor survival and immune infiltrates in hepatocellular carcinoma. Our study suggests that PBK can be used as a biomarker of poor prognosis and potential immune therapy target in hepatocellular carcinoma.https://doi.org/10.1186/s12957-021-02479-wPDZ-binding kinase (PBK)Hepatocellular carcinoma (HCC)Tumor-infiltrating immune cells (TIICs)Bioinformatics analysisSignaling pathways
spellingShingle Wei Mu
Yaoli Xie
Jinhu Li
Runzhi Yan
Jingxian Zhang
Yu’e Liu
Yimin Fan
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
World Journal of Surgical Oncology
PDZ-binding kinase (PBK)
Hepatocellular carcinoma (HCC)
Tumor-infiltrating immune cells (TIICs)
Bioinformatics analysis
Signaling pathways
title High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
title_full High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
title_fullStr High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
title_full_unstemmed High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
title_short High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
title_sort high expression of pdz binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
topic PDZ-binding kinase (PBK)
Hepatocellular carcinoma (HCC)
Tumor-infiltrating immune cells (TIICs)
Bioinformatics analysis
Signaling pathways
url https://doi.org/10.1186/s12957-021-02479-w
work_keys_str_mv AT weimu highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT yaolixie highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT jinhuli highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT runzhiyan highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT jingxianzhang highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT yueliu highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma
AT yiminfan highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma